In Pursuit of
Advancing Neurosurgery
At PrimaNova®, we are revolutionizing neurosurgery with innovative solutions that transform patient care. By combining advanced technologies with a deep understanding of neurological complexities, we empower neurosurgeons to tackle even the most challenging cases with confidence. Our goal is to fundamentally change treatment paradigms and redefine the standard of care.
Development Timeline
Key Milestones
2019
Inception
Building the next leader in innovative neurosurgical medtech
2020
Series A Financing
Completion of first financing round
2021
Series A1 Financing
Capital raised to bolster product research and development
2023
Partnership with NeuroCarta and Equity Investment
NeuroCarta is developing an intraoperative cortical stimulation system invented by neuro-oncology expert Professor Mitchel S. Berger
2023
Partnership with Panda Surgical and Seed Financing
Panda Surgical is a University College London spinout company developing a handheld robotic system offering increased dexterity and safety of minimally invasive neurosurgery
2023
Series A2 Financing
Investment from VCs and family offices providing capital for product and clinical developments
2023
MedTech Innovator APAC Finalist
Shortlisted as one of the finalist of the MedTech Innovator APAC2023 Cohort
2024
Acceptance into the HKSTP IncuBio Programme
Pre-eminent healthcare incubation program in Hong Kong
2024
Investment from Shanghai Healthcare Capital
PrimaNova partners with Shanghai Healthcare Capital, a healthcare investment firm with 50 billion RMB AUM, to revitalize neurosurgery and neurocritical care.
2024
Completion of NMPA clinical trial for PrimaNova Neurointensive Monitor
Investors & Collaborators